Preparation and characterization of cationic PLGA nanospheres as DNA carriers

被引:408
作者
Kumar, MNVR [1 ]
Bakowsky, U [1 ]
Lehr, CM [1 ]
机构
[1] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-66123 Saarbrucken, Germany
关键词
biodegradable; chitosan; gene therapy; nanoparticles; PLGA;
D O I
10.1016/j.biomaterials.2003.08.069
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
Nanoparticles formulated from biodegradable polymers such as poly(lactic acid) (PLA) and poly(lactide-co-glycolide) (PLGA) are being extensively investigated as non-viral gene delivery systems due to their controlled release characteristics and biocompatibility. PLGA nanoparticles for DNA delivery are mainly formulated by an emulsion-solvent evaporation technique using PVA as a stabilizer generating negatively charged particles and heterogeneous size distribution. The objective of the present study was to formulate cationically modified PLGA nanoparticles with defined size and shape that can efficiently bind DNA. An Emulsion-diffusion-evaporation technique to make cationic nanospheres composed of biodegradable and biocompatible co-polyester PLGA has been developed. PVA-chitosan blend was used to stabilize the PLGA nanospheres. The nanospheres were characterized by atomic force microscopy (AFM), photon-correlation spectroscopy (PCS), and Fourier transform infrared spectroscopy (FTIR). Zeta potential and gel electrophoresis studies were also performed to understand the surface properties of nanospheres and their ability to condense negatively charged DNA. The designed nanospheres have a zeta potential of 10 mV at pH 7.4 and size under 200 nm. From the gel electrophoresis studies we found that the charge on the nanospheres is sufficient to efficiently bind the negatively charged DNA electrostatically. These cationic PLGA nanospheres could serve as potential alternatives of the existing negatively charged nanoparticles. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1771 / 1777
页数:7
相关论文
共 25 条
[1]
PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[2]
Baeyens V, 1997, Pharm Acta Helv, V72, P191
[3]
Thermodynamic parameters on poly(D,L-lactide-co-glycolide) particle size in emulsification-diffusion process [J].
Choi, SW ;
Kwon, HY ;
Kim, WS ;
Kim, JH .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2002, 201 (1-3) :283-289
[4]
Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis [J].
Cohen-Sacks, H ;
Najajreh, Y ;
Tchaikovski, V ;
Gao, G ;
Elazer, V ;
Dahan, R ;
Gati, I ;
Kanaan, M ;
Waltenberger, J ;
Golomb, G .
GENE THERAPY, 2002, 9 (23) :1607-1616
[5]
Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers [J].
Feng, SS ;
Huang, GF .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) :53-69
[6]
NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT [J].
FESSI, H ;
PUISIEUX, F ;
DEVISSAGUET, JP ;
AMMOURY, N ;
BENITA, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) :R1-R4
[7]
DEVELOPMENT OF BIODEGRADABLE AND INJECTABLE LATTICES FOR CONTROLLED RELEASE OF POTENT DRUGS [J].
GURNY, R ;
PEPPAS, NA ;
HARRINGTON, DD ;
BANKER, GS .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1981, 7 (01) :1-25
[8]
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[9]
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy [J].
Konan, YN ;
Cerny, R ;
Favet, J ;
Berton, M ;
Gurny, R ;
Allémann, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (01) :115-124
[10]
Chitosan as a nonviral gene delivery system.: Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo [J].
Köping-Höggård, M ;
Tubulekas, I ;
Guan, H ;
Edwards, K ;
Nilsson, M ;
Vårum, KM ;
Artursson, P .
GENE THERAPY, 2001, 8 (14) :1108-1121